tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Verdult, 14 are a BUY (56%), 9 are a HOLD (36%), 2 are a SELL (8%).
Analyst Peter Verdult, currently employed at CITI, carries an average stock price target met ratio of 16.67% that have a potential upside of 4.04% achieved within 47 days.
Peter Verdult’s has documented 49 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SNY, Sanofi ADR at 20-Mar-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/20/2021. The price target of $41.57 was fulfilled within 184 days with a profit of $8.53 (25.82%) receiving and performance score of 1.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$22
$-12.1 (-35.48%)
$31
8 months 4 days ago
(13-Feb-2025)
3/6 (50%)
$-3.44 (-13.52%)
376
Sell
$82.77
8 months 25 days ago
(22-Jan-2025)
2/7 (28.57%)
$-1.59 (-1.88%)
32
Sell
$49
8 months 25 days ago
(22-Jan-2025)
2/5 (40%)
$2.78 (6.01%)
49
Hold
$30
$-4.1 (-12.02%)
$38
11 months 17 days ago
(31-Oct-2024)
12/14 (85.71%)
$3.11 (11.57%)
42
Sell
$31
$-3.1 (-9.09%)
$44
1 years 6 months 17 days ago
(31-Mar-2024)
6/9 (66.67%)
$-1.48 (-4.56%)
14
What Year was the first public recommendation made by Peter Verdult?
